company background image
OGI logo

Organigram Holdings NasdaqGS:OGI Stock Report

Last Price

US$1.52

Market Cap

US$167.0m

7D

5.6%

1Y

17.8%

Updated

24 Nov, 2024

Data

Company Financials +

Organigram Holdings Inc.

NasdaqGS:OGI Stock Report

Market Cap: US$167.0m

OGI Stock Overview

Through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. More details

OGI fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Organigram Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Organigram Holdings
Historical stock prices
Current Share PriceCA$1.52
52 Week HighCA$2.91
52 Week LowCA$1.20
Beta1.13
11 Month Change-17.84%
3 Month Change-23.62%
1 Year Change17.83%
33 Year Change-82.41%
5 Year Change-85.87%
Change since IPO-82.34%

Recent News & Updates

Organigram: Why I Still Like It

Sep 15

Organigram: Q3 2024 Earnings Show Improvement In Revenues And Net Income (Hold)

Aug 14

Organigram Has Declined A Lot And Is A Great Deal

Jun 23

Recent updates

Organigram: Why I Still Like It

Sep 15

Organigram: Q3 2024 Earnings Show Improvement In Revenues And Net Income (Hold)

Aug 14

Organigram Has Declined A Lot And Is A Great Deal

Jun 23

Organigram: Operating In A Structurally Challenged Industry

Apr 20

Don't Rule Out A Bull Market (Podcast Transcript)

Aug 02

Don't Rule Out A Bull Market

Jul 27

Organigram revenue of $38.12M beats by $12.05M, sees Q4 revenue higher than Q3

Jul 14

OrganiGram: Canadian Cannabis Remains Tough To Own

Apr 26

Why OrganiGram Should Generate Consistent Growth Going Forward

Jan 16

OrganiGram: Positive Signs, But Struggles Persist

Jul 14

OrganiGram Holdings (OGI) Investor Presentation - Slideshow

Jun 16

Organigram CEO Greg Engel to step down

May 03

OrganiGram: The Hype Is Over

Apr 27

Organigram EPS misses by $0.14, beats on revenue

Jan 12

Shareholder Returns

OGIUS PharmaceuticalsUS Market
7D5.6%1.6%2.2%
1Y17.8%9.9%31.6%

Return vs Industry: OGI exceeded the US Pharmaceuticals industry which returned 9.9% over the past year.

Return vs Market: OGI underperformed the US Market which returned 31.6% over the past year.

Price Volatility

Is OGI's price volatile compared to industry and market?
OGI volatility
OGI Average Weekly Movement6.2%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.3%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: OGI has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: OGI's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010984Beena Goldenbergwww.organigram.ca

Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis.

Organigram Holdings Inc. Fundamentals Summary

How do Organigram Holdings's earnings and revenue compare to its market cap?
OGI fundamental statistics
Market capUS$167.02m
Earnings (TTM)-US$164.18m
Revenue (TTM)US$106.75m

1.6x

P/S Ratio

-1.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OGI income statement (TTM)
RevenueCA$149.21m
Cost of RevenueCA$114.13m
Gross ProfitCA$35.07m
Other ExpensesCA$264.55m
Earnings-CA$229.48m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-2.11
Gross Margin23.51%
Net Profit Margin-153.80%
Debt/Equity Ratio0.06%

How did OGI perform over the long term?

See historical performance and comparison